CXCL13 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells by Inhibiting miR-23a Expression
CXC chemokines are essential for osteogenic differentiation of bone mesenchymal stem cells (BMSCs) for use in bone tissue engineering and regenerative medicine in clinical settings. However, an accurate understanding of the underlying mechanisms is still needed. In this study, we analyzed the effect...
| Autors principals: | , , , , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
Hindawi Limited
2015-01-01
|
| Col·lecció: | Stem Cells International |
| Accés en línia: | http://dx.doi.org/10.1155/2015/632305 |